ed is a Section 3(cX1) or 3(cX7) Company and has obtained consent to its treatment as a qualified purchaser from all of its ere-April 30 Holders. XL Investors that checked VI or VII may check XI Instead of X The Undersigned has obtained consent to its treatment as a Quaid-led purchaser from all of its t